TABLE OF CONTENTS
| | | | Volume 49, Issue 7 (July 2014) | | In this issue Reviews Special Report Original Articles Technical Report Letters To The Editor Corrigenda Also new AOP | | | | | Advertisement | | NEW DEALS: Lab equipment and services Browse our library of savings and information! Check Marketplace first VISIT MARKETPLACE TODAY | | | | | | Reviews | Top | | Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation M Mohty, K Hübel, N Kröger, M Aljurf, J Apperley, G W Basak, A Bazarbachi, K Douglas, I Gabriel, L Garderet, C Geraldes, O Jaksic, M W Kattan, Z Koristek, F Lanza, R M Lemoli, L Mendeleeva, G Mikala, N Mikhailova, A Nagler, H C Schouten, D Selleslag, S Suciu, A Sureda, N Worel, P Wuchter, C Chabannon and R F Duarte Bone Marrow Transplant 2014 49: 865-872; advance online publication, March 31, 2014; 10.1038/bmt.2014.39 Abstract | Full Text | | | | Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers Y-J Chang and X-J Huang Bone Marrow Transplant 2014 49: 873-879; advance online publication, February 24, 2014; 10.1038/bmt.2014.19 Abstract | Full Text | | Special Report | Top | | Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee R N Lown, J Philippe, W Navarro, S M van Walraven, L Philips-Johnson, M Fechter, R Pawson, M Bengtsson, M Beksac, S Field, H Yang and B E Shaw Bone Marrow Transplant 2014 49: 880-886; advance online publication, April 7, 2014; 10.1038/bmt.2014.67 Abstract | Full Text | | Original Articles | Top | | ACUTE LEUKEMIA | Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation L Tucunduva, A Ruggeri, G Sanz, S Furst, G Socié, M Michallet, W Arcese, N Milpied, I Yakoub-Agha, W Linkesch, J Cornelissen, L Mannone, A P Iori, J-M Ribera, J Sanz, P Montesinos, D Purtill, M Labopin, E Gluckman, M Mohty and V Rocha Bone Marrow Transplant 2014 49: 887-894; 10.1038/bmt.2014.72 Abstract | Full Text | | | | Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation J Tischer, N Engel, S Fritsch, D Prevalsek, M Hubmann, C Schulz, A K Zoellner, V Bücklein, S Lippl, R Reibke, C T Rieger, G Ledderose, H J Stemmler, W Hiddemann, C Schmid and A Hausmann Bone Marrow Transplant 2014 49: 895-901; advance online publication, May 12, 2014; 10.1038/bmt.2014.83 Abstract | Full Text | | LYMPHOMA | Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group E Tse, T S Y Chan, L-P Koh, W-J Chng, W-S Kim, T Tang, S-T Lim, A K W Lie and Y-L Kwong Bone Marrow Transplant 2014 49: 902-906; advance online publication, April 28, 2014; 10.1038/bmt.2014.65 Abstract | Full Text | | PLASMA CELL DISORDERS | Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma D M Greenfield, E Boland, Y Ezaydi, R J M Ross, S H Ahmedzai, J A Snowden and Late Effects Group Bone Marrow Transplant 2014 49: 907-912; advance online publication, April 7, 2014; 10.1038/bmt.2014.63 Abstract | Full Text | | INHERITED AND GENETIC DISORDERS | Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease M Bhatia, Z Jin, C Baker, M B Geyer, K Radhakrishnan, E Morris, P Satwani, D George, J Garvin, G Del Toro, W Zuckerman, M T Lee, M Licursi, R Hawks, E Smilow, L A Baxter-Lowe, J Schwartz and M S Cairo Bone Marrow Transplant 2014 49: 913-920; advance online publication, May 5, 2014; 10.1038/bmt.2014.84 Abstract | Full Text | | GRAFT SOURCE | Feasibility of marrow harvesting from pediatric sibling donors without hematopoietic growth factors and allotransfusion M Yabe, T Morimoto, T Shimizu, T Koike, H Takakura, K Ohtsubo, A Fukumura, S Kato and H Yabe Bone Marrow Transplant 2014 49: 921-926; advance online publication, April 28, 2014; 10.1038/bmt.2014.73 Abstract | Full Text | | | | EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantation H-t Wang, Y-j Chang, L-p Xu, D-h Liu, Y Wang, K-y Liu and X-j Huang Bone Marrow Transplant 2014 49: 927-933; advance online publication, April 28, 2014; 10.1038/bmt.2014.80 Abstract | Full Text | | CELLULAR THERAPY | Human AdV-specific T cells: persisting in vitro functionality despite lethal irradiation R Geyeregger, C Freimüller, J Stemberger, G Fischer, V Witt and G Fritsch Bone Marrow Transplant 2014 49: 934-941; advance online publication, April 28, 2014; 10.1038/bmt.2014.86 Abstract | Full Text | | GRAFT MANIPULATION | Negative selection by apoptosis enriches progenitors in naïve and expanded human umbilical cord blood grafts K Mizrahi, S Ash, T Peled, I Yaniv, J Stein and N Askenasy Bone Marrow Transplant 2014 49: 942-949; advance online publication, April 28, 2014; 10.1038/bmt.2014.79 Abstract | Full Text | | SUPPORTIVE CARE | Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT T Czerw, M Labopin, N-C Gorin, S Giebel, D Blaise, P-Y Dumas, R Foa, M Attal, N Schaap, M Michallet, C Bonmati, H Veelken and M Mohty Bone Marrow Transplant 2014 49: 950-954; advance online publication, April 7, 2014; 10.1038/bmt.2014.64 Abstract | Full Text | | CONDITIONING | A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies M Gotoh, S Yoshizawa, S Katagiri, T Suguro, M Asano, T Kitahara, D Akahane, S Okabe, T Tauchi, Y Ito and K Ohyashiki Bone Marrow Transplant 2014 49: 955-960; advance online publication, April 14, 2014; 10.1038/bmt.2014.66 Abstract | Full Text | | TRANSPLANT TOXICITIES | Accuracy of self-reported tobacco use status among hematopoietic SCT patients S L Ehlers, C A Bronars, C A Patten, T Brockman, C Hughes, P A Decker, J R Cerhan, W Hogan, A Dispenzieri, S Ansell, J Ebbert and D Gastineau Bone Marrow Transplant 2014 49: 961-965; advance online publication, April 14, 2014; 10.1038/bmt.2014.70 Abstract | Full Text | | GRAFT-VERSUS-HOST DISEASE | Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation C Castilla-Llorente, P J Martin, G B McDonald, B E Storer, F R Appelbaum, H J Deeg, M Mielcarek, H Shulman, R Storb and R A Nash Bone Marrow Transplant 2014 49: 966-971; advance online publication, April 28, 2014; 10.1038/bmt.2014.69 Abstract | Full Text | | | | Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD Q Ma, D Li, R Carreño, R Patenia, K Y Tsai, M Xydes-Smith, A M Alousi, R E Champlin, G E Sale and V Afshar-Kharghan Bone Marrow Transplant 2014 49: 972-976; advance online publication, April 28, 2014; 10.1038/bmt.2014.75 Abstract | Full Text | | Technical Report | Top | | Estimation of size of cord blood inventory based on high-resolution typing of HLAs E Y Song, J Y Huh, S Y Kim, T G Kim, S Oh, J H Yoon, E Y Roh, M H Park, M S Kang and S Shin Bone Marrow Transplant 2014 49: 977-979; advance online publication, April 28, 2014; 10.1038/bmt.2014.76 Abstract | Full Text | | Letters To The Editor | Top | | Feasibility of umbilical cord blood transplantation with a myeloablative, reduced toxicity-conditioning regimen M Nishimoto, H Nakamae, M Nakamae, A Hirose, K Hagihara, H Koh, T Nakane, Y Terada and M Hino Bone Marrow Transplant 2014 49: 980-981; advance online publication, April 7, 2014; 10.1038/bmt.2014.60 Full Text | | | | Systemic lupus erythematosus complicated with thymoma and pure red cell aplasia (PCRA). CR of both complications following thymectomy and allogeneic haematopoietic SCT (HSCT), but persistence of antinuclear antibodies (ANA) A M Marmont, A Bacigalupo, F Gualandi, S Bregante, M T van Lint and S Geroldi Bone Marrow Transplant 2014 49: 982-983; advance online publication, May 12, 2014; 10.1038/bmt.2014.68 Full Text | | | | Treatment of acute mixed-cell leukemia with autologous hematopoietic SCT followed by allogeneic hematopoietic stem cell micro-transplantation Y-S Chen, X-J Kong, X-H Zhang and X-L Yin Bone Marrow Transplant 2014 49: 984-985; advance online publication, April 14, 2014; 10.1038/bmt.2014.74 Full Text | | Neuropathic dermatomes and cutaneous ulceration in patients with chronic GVHD R T Kamble, A Scholoff, A G Obi, H E Heslop, M K Brenner and G Carrum Bone Marrow Transplant 2014 49: 986-987; advance online publication, April 28, 2014; 10.1038/bmt.2014.77 Full Text | | | | Isolated orbital relapse of multiple myeloma in a patient with severe chronic GVHD after allogeneic hematopoietic SCT C Blecha, D Wolff, O Kölbl, E Huber, H Helbig, B Holler, E Holler and T Dietrich-Ntoukas Bone Marrow Transplant 2014 49: 988-989; advance online publication, April 28, 2014; 10.1038/bmt.2014.81 Full Text | | | | The commitment and evaluation of the quality management plan by professionals from accredited stem cell transplant centers in Spain M-J Jiménez, C Ferra, O García, F de Arriba, S Jiménez, A Insunza, M Calabuig, A Mantecon, J Sánchez, M Torres, P Balsalobre, J Linio, A Jiménez, E Feliu and J-M Ribera Bone Marrow Transplant 2014 49: 990-992; advance online publication, April 28, 2014; 10.1038/bmt.2014.85 Full Text | | | | Peanut allergy transferred by BMT W Ip, C Cale, P Veys and W Qasim Bone Marrow Transplant 2014 49: 993-994; advance online publication, April 28, 2014; 10.1038/bmt.2014.95 Full Text | | Corrigenda | Top | | Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma D M Greenfield, E Boland, Y Ezaydi, R J M Ross, S H Ahmedzai and J A Snowden on behalf of the Late Effects Group Bone Marrow Transplant 2014 49: 995; advance online publication, May 19, 2014; 10.1038/bmt.2014.103 Full Text | | | | Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT S V Glavey, M A Gertz, A Dispenzieri, S Kumar, F Buadi, M Lacy, S R Hayman, P Kapoor, D Dingli, A McCurdy, W J Hogan, D A Gastineau and N Leung Bone Marrow Transplant 2014 49: 996; 10.1038/bmt.2014.24 Full Text | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | | | |
No comments:
Post a Comment